Cite
HARVARD Citation
Gu, W. et al. (n.d.). Efficacy and safety of saxagliptin monotherapy or added to metformin in Chinese patients with type 2 diabetes mellitus: results from the 24‐week, post‐marketing SUNSHINE study*†. Journal of diabetes. pp. 809-815. [Online].